U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
By Jan Wolfe (Reuters) – A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a...
Read More